[Characteristics of the functional activity of leukocytes in diabetes mellitus].

[Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy]. Ter Arkh (2008) 0.84

Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Mosc) (2003) 0.81

[Hyperhomocysteinemia in coronary artery disease and hemostasis disorders in patients with type 2 diabetes mellitus]. Klin Med (Mosk) (2007) 0.77

[Obesity and chronic kidney disease]. Ter Arkh (2011) 0.77

[Leukocyte migration inhibition test as an indicator of viral allergy in systemic lupus erythematosus]. Lab Delo (1975) 0.75

[Early diagnosis of carbohydrate metabolism disorders in patients with essential hypertension]. Klin Med (Mosk) (1987) 0.75

[Prevalence of main risk factors for development of acute disturbance of brain blood circulation in patients with diabetes mellitus type 2]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.75

[Characteristics of delayed hypersensitivity in systemic lupus erythematosus according to blast-transformation test under the effect of viral antigen]. Vopr Revm (1974) 0.75

[Pathogenetic therapy of tissue hypoxia, hemorheologic disorders and microangiopathies in patients with diabetes mellitus]. Ter Arkh (1990) 0.75

[The interferon status in diabetes mellitus]. Ter Arkh (1993) 0.75

[Urinary excretion of fibrogenic and antifibrotic growth factors in type 1 diabetic patients: the interrelationship with diabetic nephropathy]. Ter Arkh (2012) 0.75

[Blood hyperviscosity syndrome in type I diabetes mellitus]. Probl Endokrinol (Mosk) (1989) 0.75

[Predictive value of insulin-glucose homeostasis markers in patients with metabolic syndrome X]. Ter Arkh (2002) 0.75

[Delayed-type hypersensitivity in insulin-dependent diabetes mellitus and effects of short-action insulins produced by different pharmaceutical firms]. Ter Arkh (1998) 0.75

[Content of sex X and Y chromatin in systemic lupus erythematosus]. Klin Med (Mosk) (1975) 0.75

[Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma]. Klin Med (Mosk) (1973) 0.75

[Blood rheological disorders in diabetes mellitus]. Ter Arkh (1982) 0.75

[The characteristics of the peripheral blood monocytes in diabetics]. Ter Arkh (1997) 0.75

[Oxygen transport system and tissue oxygenation at early stages of diabetes mellitus]. Ter Arkh (1981) 0.75

[Blood lipids, oxygen balance of tissues and microcirculatory disorders in diabetes mellitus]. Ter Arkh (1978) 0.75

[Glycosylated proteins and the rheological properties of the erythrocytes in carbohydrate metabolic disorders]. Ter Arkh (1991) 0.75

[Thymogen in the treatment of type-1 diabetes mellitus]. Ter Arkh (1996) 0.75

[Diabetes mellitus and the transport function of glycosylated and nonglycosylated albumin]. Ter Arkh (1990) 0.75

[Lipid peroxidation in patients with diabetes mellitus]. Probl Endokrinol (Mosk) (1988) 0.75

[Thibierge-Weissenbach syndrome as the 1st manifestation of systemic scleroderma]. Ter Arkh (1981) 0.75

[Blood rheological properties and the oxygen balance of the tissues in experimental alloxan diabetes]. Probl Endokrinol (Mosk) (1983) 0.75

[Hospital infections in patients with hematologic diseases]. Probl Gematol Pereliv Krovi (1982) 0.75

[Free fatty acid spectrum and rheological properties of erythrocytes in people with disturbed glucose tolerance and in patients with diabetes mellitus]. Probl Endokrinol (Mosk) (1991) 0.75

[Contractile function of the myocardium and oxygen metabolism in diabetes mellitus]. Ter Arkh (1985) 0.75

[Importance of estimated value of T-cell activation in insulin-dependent diabetes mellitus]. Ter Arkh (1999) 0.75

[Clinical and metabolic risk factors for cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus]. Ter Arkh (2010) 0.75

[Treatment of diabetes mellitus in dialysis patients]. Ter Arkh (2011) 0.75

[Clinico-immunologic subtypes of type I diabetes mellitus]. Ter Arkh (2002) 0.75

[Diabetic microangiopathy and oxygen transport disorder (a review of the literature and the authors' own data)]. Ter Arkh (1986) 0.75

[Leukocytic interferon in systemic lupus erythematosus]. Sov Med (1972) 0.75

[The effect of various inducers on interferon-synthesizing activity of leukocytes in patients with diabetes mellitus]. Vopr Virusol (1990) 0.75

[Diagnostic significance of determining glycosylated hemoglobin in the detection of early forms of diabetes mellitus]. Probl Endokrinol (Mosk) (1988) 0.75

[The characteristics of T-lymphocyte differentiation in type-1 diabetes mellitus]. Ter Arkh (1995) 0.75

[Glycosylation products in the early diagnosis and prognostic evaluation of carbohydrate metabolism disorders]. Probl Endokrinol (Mosk) (1993) 0.75

[The diurnal blood pressure and the EchoCG parameters of the left ventricle in patients with diabetic nephropathy]. Klin Med (Mosk) (2004) 0.75

[The role of glycosylated hemoglobin in the etiology of hypoxia in diabetes mellitus]. Klin Med (Mosk) (1983) 0.75

[Rheopolyglucin in the combined therapy of diabetics]. Probl Endokrinol (Mosk) (1986) 0.75

[Desynchronization of circadian rhythms of the oxygen balance in the tissues and rheological properties of the blood in type I diabetes mellitus]. Ter Arkh (1988) 0.75

[Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects]. Ter Arkh (1995) 0.75

[Immunological aspects of diabetic angiopathies pathogenesis]. Ter Arkh (1998) 0.75

[Secretory potentialities of beta cells at early stages of diabetes mellitus]. Med Radiol (Mosk) (1986) 0.75

[Chronic viral infection in rheumatism and systemic lupus erythematosus]. Vopr Virusol (1976) 0.75

[Comparative analysis of methods of determining glycosylated hemoglobin]. Lab Delo (1988) 0.75

[The characteristics of the immunogenesis and immunocorrection of diabetes mellitus]. Ter Arkh (1995) 0.75

[Leukocytolysis reaction in the detection of viral allergy in patients with systemic lupus erythematosus]. Sov Med (1975) 0.75

[Hemoglobin A1C and tissue oxygen balance in compensated diabetes mellitus]. Klin Med (Mosk) (1987) 0.75

[Interferon-synthesizing function of leukocytes in patients with diabetes mellitus]. Ter Arkh (1986) 0.75

[Blood lipids and the biomicroscopy of the bulbar conjunctiva in diabetes mellitus]. Klin Med (Mosk) (1978) 0.75

[Clinical significance of the determination of glycosylated hemoglobins in diabetes mellitus]. Probl Endokrinol (Mosk) (1984) 0.75